We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Surgical Treatment for Congestive Heart Failure

By HospiMedica staff writers
Posted on 20 Oct 2004
A new minimally invasive surgical treatment for congestive heart failure involves a heart reshaping procedure (HRP) that can be performed through a small chest incision.

In severe cases of congestive heart failure, the heart is enlarged and the pumping action of the left ventricle has become inefficient. More...
Although frequently performed through an operation that requires division of the breastbone, in many cases the ventricle can be accessed for reshaping using a minimally invasive approach.

In HRP, the surgeon introduces a custom-engineered device called the Blue Egg Sizer into the left ventricle and surgically reshapes the heart around the device. In the final step, the surgeon collapses the Blue Egg Sizer, removes it from the ventricle, and attaches a cloth patch specifically designed for this operation to seal the hole. The heart returns to its original elliptical shape and is better able to circulate blood to meet the body's needs. HRP can also be performed in conjunction with other heart failure treatments such as cardiac stenting and bypass grafting.

The first minimally invasive HRP in the United States was recently performed in St. Joseph's Hospital (Tacoma, WA, USA) by Wendel Smith, M.D., who works closely with St. Joseph's cardiologists, led by Dr. Raed Fahmy, to select patients who are candidates for the HRP procedure. "There was an immediate improvement in the patient's cardiac output following the procedure,” Dr. Smith stated. The Blue Egg Sizer is being distributed by CHF Technologies, Inc. (Danville, CA, USA).




Related Links:
CHF Technologies

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.